Tyrosine Kinase Inhibitors: Global Market Outlook

Dec 2023| BIO242A| BCC Publishing
Inquire Now

Report Highlights

This report provides a detailed understanding of the current market scenario for tyrosine kinase inhibitors and an assessment of the market’s growth over the period from 2023 through the end of 2028. The report highlights major trends and challenges that affect the global market and the vendor landscape.

Report Includes

  • An overview of the global market for tyrosine kinase inhibitors
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Definition of tyrosine kinase inhibitors and their characteristics, and coverage of the market’s dynamics, specifically drivers, inhibitors and opportunities
  • Discussions of novel tyrosine kinase inhibitors and their utility in the human trials
  • Examination of the technologies and methods used for the creation of novel targets and their therapeutic approaches
  • Discussions of market challenges and how to overcome them if the market is to reach its commercialization potential, pipeline drugs and relevant patents
  • Information on recent mergers and acquisitions, collaborations, partnerships and product introductions
  • Profiles of major players in the market

Report Scope

In this report, the market has been segmented based on type, application and geography. The report provides an overview of the global tyrosine kinase inhibitor market and analyzes market trends. Using 2022 as the base year, the report provides estimated market data for the forecast period of 2023 through 2028. Market values have been estimated based on the total revenue of tyrosine kinase inhibitor product providers.

The report covers the market for tyrosine kinase inhibitors with regard to the user base across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. The report estimates the global market for tyrosine kinase inhibitors in 2022 and provides projections for the expected market size through 2028. The scope of the study includes tyrosine kinase inhibitor drugs that are already available in the market as well as future prospects.

Frequently Asked Questions (FAQs)

The global market for tyrosine kinase inhibitors was valued at $44.7 billion in 2022 and is expected to grow at a CAGR of 6.5% to nearly $65.1 billion by 2028.
The global market for tyrosine kinase inhibitors is witnessing intrinsic growth owing to increasing incidence of cancer, rise in healthcare expenditure & government funding in key countries and robust clinical drug pipelines.
The tyrosine kinase inhibitors market is segmented based on type, application, and region.
The Receptor Tyrosine Kinase Inhibitor segment will dominate the market in 2028 and Non-receptor Tyrosine Kinase Inhibitor will grow with the highest CAGR in the forecasted period.
North America holds the highest share of the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $44.7 billion
Market size forecast $65.1 billion
Growth rate CAGR of 6.5% from 2023 to 2028
Units considered $ Millions
Segments covered By Type, Application, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers
  • Increasing Incidence of Cancer
  • Rise in Healthcare Expenditures and Government Funding in Key Countries
  • Robust Clinical Drug Pipeline
Companies studied

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Tyrosine Kinase Inhibitors: Global Market Outlook75Free
Tyrosine Kinase Inhibitors: Global Market Outlook

Single User License: $3500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.